{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:23:07Z","timestamp":1791894187042,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1676,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/jid.2011.41","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T09:43:06Z","timestamp":1299750186000},"page":"1045-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Statins Downregulate K6a Promoter Activity: A Possible Therapeutic Avenue for Pachyonychia Congenita"],"prefix":"10.1016","volume":"131","author":[{"given":"Yiwei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances J.D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Irwin","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.41_bb0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.21521","article-title":"Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?","volume":"54","author":"Abeles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2011.41_bb0015","first-page":"187","article-title":"Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins","volume":"3","author":"Bernerd","year":"1993","journal-title":"Gene Expr"},{"key":"10.1038\/jid.2011.41_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2011.41_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng0795-363","article-title":"Mutation of a type II keratin gene (K6a) in pachyonychia congenita","volume":"10","author":"Bowden","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2011.41_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0021-9258(17)38120-6","article-title":"Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase","volume":"253","author":"Brown","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2011.41_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1073\/pnas.97.1.91","article-title":"IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages","volume":"97","author":"Contursi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.41_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/343177a0","article-title":"Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene","volume":"343","author":"de The","year":"1990","journal-title":"Nature"},{"key":"10.1038\/jid.2011.41_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jir.1997.17.121","article-title":"GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression","volume":"17","author":"Decker","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"10.1038\/jid.2011.41_bb0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd1382","article-title":"Key factors in the rising cost of new drug discovery and development","volume":"3","author":"Dickson","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/jid.2011.41_bb0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archdermatol.2010.81","article-title":"Fracturing support for the role of systemic retinoid therapy as a cause of bone demineralization","volume":"146","author":"DiGiovanna","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2011.41_bb0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1289\/ehp.10696","article-title":"A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes","volume":"116","author":"Endo","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1038\/jid.2011.41_bb0065","doi-asserted-by":"crossref","first-page":"30730","DOI":"10.1074\/jbc.M205225200","article-title":"Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence","volume":"277","author":"Erickson","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2011.41_bb0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1523-1747.2001.01327.x","article-title":"Keratins and the keratinocyte activation cycle","volume":"116","author":"Freedberg","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cytogfr.2008.08.004","article-title":"IFNgamma signaling-does it mean JAK-STAT?","volume":"19","author":"Gough","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/jid.2011.41_bb0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1523-1747.2002.01843.x","article-title":"Interferon-gamma, a strong suppressor of cell proliferation, induces upregulation of keratin K6, one of the inflammatory- and proliferation-associated keratins","volume":"119","author":"Hattori","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0085","series-title":"J Invest Dermatol","article-title":"Use of self-delivery siRNAs to inhibit gene expression in an organotypic pachyonychia congenita model","author":"Hickerson","year":"2011"},{"key":"10.1038\/jid.2011.41_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1196\/annals.1348.059","article-title":"SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita","volume":"1082","author":"Hickerson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/jid.2011.41_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5701060","article-title":"Single-nucleotide-specific siRNA targeting in a dominant-negative skin model","volume":"128","author":"Hickerson","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0100","first-page":"3951","article-title":"The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds","volume":"13","author":"Kanno","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1038\/jid.2011.41_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1087-0024.2005.10208.x","article-title":"Challenges in developing therapies for rare diseases including pachyonychia congenita","volume":"10","author":"Kaspar","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.41_bb0110","series-title":"J Invest Dermatol 131","first-page":"1011","article-title":"Toward a treatment for PC: report on the 7th annual International Pachyonychia Congenita Consortium meeting","author":"Kaspar","year":"2011"},{"key":"10.1038\/jid.2011.41_bb0115","doi-asserted-by":"crossref","first-page":"14460","DOI":"10.1073\/pnas.0706486104","article-title":"Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex","volume":"104","author":"Kerns","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2011.41_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1523-1747.2001.01249.x","article-title":"Interleukin-1 induces transcription of keratin K6 in human epidermal keratinocytes","volume":"116","author":"Komine","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","article-title":"Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita","volume":"51","author":"Leachman","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2011.41_bb0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2011.41_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1087-0024.2005.10202.x","article-title":"Clinical and pathological features of pachyonychia congenita","volume":"10","author":"Leachman","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2011.41_bb0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1189\/jlb.1206739","article-title":"Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha","volume":"82","author":"Lee","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1038\/jid.2011.41_bb0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2007.07.003","article-title":"A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita","volume":"48","author":"Liao","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2011.41_bb0150","first-page":"361","article-title":"Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members","volume":"6","author":"Ma","year":"1997","journal-title":"Gene Expr"},{"key":"10.1038\/jid.2011.41_bb0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ng0395-273","article-title":"Keratin 16 and keratin 17 mutations cause pachyonychia congenita","volume":"9","author":"McLean","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2011.41_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/jid.2011.41_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11883-999-0046-2","article-title":"New developments in the treatment of low high-density lipoprotein cholesterol","volume":"1","author":"Miller","year":"1999","journal-title":"Curr Atheroscler Rep"},{"key":"10.1038\/jid.2011.41_bb0170","first-page":"26","article-title":"Effects of ultraviolet B radiation on cytoskeletal and adhesion molecules in human epidermis","volume":"10","author":"Moll","year":"1994","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1038\/jid.2011.41_bb0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj20030754","article-title":"Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence","volume":"374","author":"Nioi","year":"2003","journal-title":"Biochem J"},{"key":"10.1038\/jid.2011.41_bb0180","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","article-title":"British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology","volume":"162","author":"Ormerod","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.41_bb0185","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.7.7b.1411","article-title":"Determinants for selective RAR and TR recognition of direct repeat HREs","volume":"7","author":"Perlmann","year":"1993","journal-title":"Genes Dev"},{"key":"10.1038\/jid.2011.41_bb0190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/1523-1747.ep12337483","article-title":"Specific organization of the negative response elements for retinoic acid and thyroid hormone receptors in keratin gene family","volume":"109","author":"Radoja","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00054556","article-title":"Cholesterol biosynthesis and metabolism","volume":"6","author":"Russell","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1038\/jid.2011.41_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/187152509789541864","article-title":"Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors","volume":"7","author":"Smaldone","year":"2009","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1038\/jid.2011.41_bb0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.jid.5701040","article-title":"Development of therapeutic siRNAs for pachyonychia congenita","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.41_bb0210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/hmg\/7.7.1143","article-title":"A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2","volume":"7","author":"Smith","year":"1998","journal-title":"Hum Molec Genet"},{"key":"10.1038\/jid.2011.41_bb0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/excr.1996.0115","article-title":"Codominant regulation of keratin gene expression by cell surface receptors and nuclear receptors","volume":"224","author":"Tomic-Canic","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1038\/jid.2011.41_bb0220","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0092-8674(91)90020-Y","article-title":"Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors","volume":"65","author":"Umesono","year":"1991","journal-title":"Cell"},{"key":"10.1038\/jid.2011.41_bb0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.2010.29","article-title":"The future is much closer collaboration between the pharmaceutical industry and academic medical centers","volume":"87","author":"Vallance","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/jid.2011.41_bb0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1248","article-title":"Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation","volume":"35","author":"Wakabayashi","year":"2003","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2011.41_bb0235","series-title":"J Invest Dermatol","article-title":"A large mutational study in pachyonychia congenita","author":"Wilson","year":"2011"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15352623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:37:23Z","timestamp":1743961043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15352623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0022202X15352623"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.41","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins Downregulate K6a Promoter Activity: A Possible Therapeutic Avenue for Pachyonychia Congenita","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.41","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}